Related references
Note: Only part of the references are listed.mTOR pathway in renal cell carcinoma
Sara C. Hanna et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Genes that affect both cell growth and polarity mediate stem cell quiescence
Patrick Narbonne et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
KEGG for linking genomes to life and the environment
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2008)
Biomarkers in clear cell renal cell carcinoma
Saby George et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2007)
Integrative Microarray analysis of pathways dysregulated in metastatic prostate cancer
Sunita R. Setlur et al.
CANCER RESEARCH (2007)
A systems biology approach for pathway level analysis
Sorin Draghici et al.
GENOME RESEARCH (2007)
Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer
Jack X. Yu et al.
BMC CANCER (2007)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The hypoxia-inducible factor 2α N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo
Qin Yan et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Opportunities and obstacles to combination targeted therapy in renal cell cancer
Jeffrey A. Sosman et al.
CLINICAL CANCER RESEARCH (2007)
Reactome: a knowledge base of biologic pathways and processes
Imre Vastrik et al.
GENOME BIOLOGY (2007)
Oncogenes, Trousseau syndrome, and cancer-related changes in the coagulome of mice and humans
Janusz Rak et al.
CANCER RESEARCH (2006)
The metabolic syndrome - A high-risk state for cancer?
Stephanie Cowey et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
The !von Hippel-Lindau tumor suppressor gene product represses oncogenic β-catenin signaling in renal carcinoma cells
Benedetta Peruzzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma
Rachel A. Craven et al.
PROTEOMICS (2006)
The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma
JS Hwa et al.
PROTEOMICS (2006)
Inhibition of bladder tumor growth by 1,1-bis(3 '-indolyl)-1-(p-substitutedphenyl)methanes: A new class of peroxisome proliferator-activated receptor gamma agonists
W Kassouf et al.
CANCER RESEARCH (2006)
Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues
RA Perego et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Pyruvate kinase type M2 and its role in tumor growth and spreading
S Mazurek et al.
SEMINARS IN CANCER BIOLOGY (2005)
Efficacy of Wnt-1 monoclonal antibody in sarcoma cells
I Mikami et al.
BMC CANCER (2005)
Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins
XM Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and clCAT with multidimensional liquid chromatography and tandem mass spectrometry
L DeSouza et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma
M Yao et al.
JOURNAL OF PATHOLOGY (2005)
TGF-beta 1 could be a missing link in the interplay between ER and HER-2 in breast cancer
N Todorovic-Rakovic
MEDICAL HYPOTHESES (2005)
Peroxisome-proliferator-activated receptors and cancers: Complex stories
L Michalik et al.
NATURE REVIEWS CANCER (2004)
The Gene Ontology (GO) database and informatics resource
MA Harris et al.
NUCLEIC ACIDS RESEARCH (2004)
Differential protein profiling in renal-cell carcinoma
T Shi et al.
MOLECULAR CARCINOGENESIS (2004)
Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data
ME Lenburg et al.
BMC CANCER (2003)
Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate
S Draghici et al.
NUCLEIC ACIDS RESEARCH (2003)
Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapy
B Seliger et al.
PROTEOMICS (2003)
Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma
S Le Jan et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
The von Hippel-Lindau gene, kidney cancer, and oxygen sensing
WG Kaelin
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification
M Takahashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
